strontium has been researched along with Neuroendocrine Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldman, B | 1 |
1 other study(ies) available for strontium and Neuroendocrine Tumors
| Article | Year |
|---|---|
Next generation of targeted radiotherapy drugs emerging from the clinical pipeline.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Disease Progression; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Neuroendocrine Tumors; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radiation-Sensitizing Agents; Radiopharmaceuticals; Receptors, Peptide; Strontium | 2004 |